2014 annual financial data

Karyopharm Therapeutics 2014 Net margin

Direct answer

Net margin was -33,090.39%.

Operating income was -75,846,000 USD and net income was -75,777,000 USD.
Operating cash flow was -51,447,000 USD.

Get free Karyopharm Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
229,000 USD
Operating income
-75,846,000 USD
Net income
-75,777,000 USD
Operating cash flow
-51,447,000 USD